Advanced search×

A review of current animal models of osteoarthritis pain.

Warren N WN D'Souza, Gordon Y GY Ng, Bradley D BD Youngblood, Wayne W Tsuji, and Sonya G SG Lehto

Curr Pharm Biotechnol 12(10):1596-612 (2011) PMID 21466452

Osteoarthritis (OA) is a complex disease plagued by a significant unmet need for treatment. To date, no disease- modifying OA drugs (DMOADs) exist and the available symptom-modifying OA drugs (SMOADs) have limitations. Although a complete understanding of the mechanisms of OA pain in humans is lacking, animal models have helped provide insight into the multifaceted origin and manifestation of OA pain. Success in discovering new therapeutics will likely require reliance on good animal models. This review summarizes the animal models available for studying pain associated with OA.

Version: za2963e q8za4 q8zbf q8zc8 q8zd2 q8ze9 q8zf0 q8zg7

Similar articles you may find interesting…

  1. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG85...
    Sonya G SG Lehto, Rami R Tamir, ... Narender R NR Gavva

    J Pharmacol Exp Ther 326(1):218-29 (2008) PMID 18420600

    We investigated the possibility of eliminating hyperthermia while maintaining antihyperalgesia. Here, we report four potent and selective TRPV1 modulators with unique in vitro pharmacology profiles (profiles A through D) and their respective effects on body temperature. We found that profile C modul...
  2. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicent...
    Stanley B SB Cohen, Robin K RK Dore, ...

    Arthritis Rheum 58(5):1299-309 (2008) PMID 18438830

    At 6 months, the increase in the MRI erosion score from baseline was lower in the 60-mg denosumab group (mean change 0.13; P = 0.118) and significantly lower in the 180-mg denosumab group (mean change 0.06; P = 0.007) than in the placebo group (mean change 1.75). A significant difference in the modi...
  3. EFFECTS OF TEMPERATURE AND WATER ACTIVITY ON THE SORPTION HEAT OF WHEY AND YOGURT POWDER SPRAY WITHIN THE TEMPERATURE RANGE 20–40C
    JIRI STENCL, BOHUMILA JANSTOVA, and MICHAELA DRACKOVA

    J Food Process Eng Ahead of Print (2009)